112 Chapter 7 REFERENCES 1. Frey JD, Salibian AA, Karp NS, Choi M. Implant-Based Breast Reconstruction: Hot Topics, Controversies, and New Directions. Plastic and reconstructive surgery. 2019;143(2):404e16e. 2. Darragh L, Robb A, Hardie CM, McDonald S, Valand P, O’Donoghue JM. Reducing implant loss rates in immediate breast reconstructions. Breast (Edinburgh, Scotland). 2017;31:20813. 3. Fischer JP, Wes AM, Tuggle CT, 3rd, Serletti JM, Wu LC. Risk analysis of early implant loss after immediate breast reconstruction: a review of 14,585 patients. Journal of the American College of Surgeons. 2013;217(6):983-90. 4. Hirsch EM, Seth AK, Kim JYS, Dumanian GA, Mustoe TA, Galiano RD, Fine NA. Analysis of risk factors for complications in expander/implant breast reconstruction by stage of reconstruction. Plastic and reconstructive surgery. 2014;134(5):692e-9e. 5. Knight HJ, Musgrove JJ, Youssef MMG, Ferguson DJ, Olsen SB, Tillett RL. Significantly reducing implant loss rates in immediate implant-based breast reconstruction: A protocol and completed audit of quality assurance. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2020;73(6):1043-9. 6. Ozturk CN, Ozturk C, Soucise A, Platek M, Ahsan N, Lohman R, et al. Expander/Implant Removal After Breast Reconstruction: Analysis of Risk Factors and Timeline. Aesthetic plastic surgery. 2018;42(1):64-72. 7. Sue GR, Sun BJ, Lee GK. Complications After Two-Stage Expander Implant Breast Reconstruction Requiring Reoperation: A Critical Analysis of Outcomes. Annals of plastic surgery. 2018;80(5S Suppl 5):S292-s4. 8. Blok YL, van Lierop E, Plat VD, Corion LUM, Verduijn PS, Krekel NMA. Implant Loss and Associated Risk Factors following Implant-based Breast Reconstructions. Plastic and reconstructive surgery Global open. 2021;9(7):e3708. 9. Vrolijk JJ, Melse PE, Becherer BE, van Bommel ACM, Hommes JE, Hoornweg MJ, et al. Dutch Breast Implant Registry (DBIR) Annual Reports. Dutch Breast Implant Registry (DBIR) Annual Report 2021: Version 202201. Leiden (NL): Dutch Institute for Clinical Auditing © 2022 DICA. All rights reserved.; 2022. 10. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (Clinical research ed). 2007;335(7624):806-8. 11. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191-4. 12. Heinze G, Wallisch C, Dunkler D. Variable selection - A review and recommendations for the practicing statistician. Biom J. 2018;60(3):431-49. 13. Chun YS, Verma K, Rosen H, Lipsitz S, Morris D, Kenney P, Eriksson E. Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. Plastic and reconstructive surgery. 2010;125(2):429-36. 14. Kato H, Nakagami G, Iwahira Y, Otani R, Nagase T, Iizaka S, et al. Risk factors and risk scoring tool for infection during tissue expansion in tissue expander and implant breast reconstruction. Breast J. 2013;19(6):618-26. 15. McCarthy CM, Mehrara BJ, Riedel E, Davidge K, Hinson A, Disa JJ, et al. Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plastic and reconstructive surgery. 2008;121(6):188692. 16. Ooi A, Song DH. Reducing infection risk in implant-based breast-reconstruction surgery: challenges and solutions. Breast Cancer (Dove Med Press). 2016;8:161-72.
RkJQdWJsaXNoZXIy MTk4NDMw